Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 0.73 is 84% below its estimated 5-year average of 4.70, near the low end of its estimated 5-year range (0.73–9.94).
As of 2026-10-06T17:07:45.273Z. 84.43% below its estimated 12-month average of 4.69.
Calculation as of: 2026-10-06T17:07:45.273Z.
Quote observation: 2026-10-06T16:38:40.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 00b46e2a658eb37d32f3c4bb775d4183c2cde6b20987a1f72f3e7425ee882fe4
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
0.73
PS RATIO AVG TTM
4.69
PS RATIO AVG 3Y
4.84
PS RATIO AVG 5Y
4.70
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-84.43%
CURRENT VS 3Y AVG
-84.90%
CURRENT VS 5Y AVG
-84.46%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.13
median of 534 covered companies
CURRENT VS SECTOR MEDIAN
-82.30%
vs the sector median at left
Market Cap
$149.18M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$147.34M
PS Ratio
N/A
TTM Avg
636.97
3Y Avg
636.97
5Y Avg
636.97
Market Cap
$151.58M
PS Ratio
N/A
TTM Avg
1654.31
3Y Avg
1654.31
5Y Avg
1654.31
Market Cap
$152.06M
PS Ratio
N/A
TTM Avg
1819.96
3Y Avg
1717.34
5Y Avg
1717.34
Market Cap
$144.23M
PS Ratio
75.91
TTM Avg
4.90
3Y Avg
9.87
5Y Avg
13.41
Market Cap
$143.60M
PS Ratio
N/A
TTM Avg
79.91
3Y Avg
79.91
5Y Avg
79.91
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMDP) | $148.31M | 0.73 | 4.69 | 4.84 | 4.70 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $149.18M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $147.34M | N/A | 636.97 | 636.97 | 636.97 |
| Anavex Life Sciences Corp. (AVXL)vs › | $146.42M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $151.15M | 1.95 | 2.61 | 3.23 | 4.75 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | N/A | 1654.31 | 1654.31 | 1654.31 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $152.06M | N/A | 1819.96 | 1717.34 | 1717.34 |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.23M | 75.91 | 4.90 | 9.87 | 13.41 |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | N/A | 79.91 | 79.91 | 79.91 |
| Nyxoah S.A. (NYXH)vs › | $143.18M | 5.46 | 16.79 | 41.83 | 132.05 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $60,172,470 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-17 |
| Q4 FY2025Period ended 2025-12-31 | $46,868,484 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-10 |
| Q1 FY2026Period ended 2026-03-31 | $50,162,956 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $47,281,085 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $204,484,995 |
Current P/S: $148,309,748 market capitalization ÷ $204,484,995 TTM revenue = 0.73x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:38:40.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 0.73, P/S is below its estimated 5-year median — higher than 0% of readings in its estimated 5-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 5-year low
3.57
median
4.76
estimated 5-year high
9.94
P/S Ratio
0.73
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 5.34 |
| 2026-10-02 | 5.31 |
| 2026-10-01 | 5.41 |
| 2026-09-30 | 5.39 |
| 2026-09-29 | 5.39 |
| 2026-09-28 | 5.41 |
| 2026-09-25 | 5.41 |
| 2026-09-24 | 5.42 |
| 2026-09-23 | 5.42 |
| 2026-09-22 | 5.46 |
| 2026-09-21 | 5.40 |
| 2026-09-18 | 5.41 |
| 2026-09-17 | 5.41 |
| 2026-09-16 | 5.45 |
| 2026-09-15 | 5.45 |
| 2026-09-14 | 5.34 |
| 2026-09-11 | 5.38 |
| 2026-09-10 | 5.38 |
| 2026-09-09 | 5.45 |
| 2026-09-08 | 5.49 |
| 2026-09-04 | 5.43 |
| 2026-09-03 | 5.49 |
| 2026-09-02 | 5.49 |
| 2026-09-01 | 5.52 |
| 2026-08-31 | 5.41 |
| 2026-08-28 | 5.44 |
| 2026-08-27 | 5.44 |
| 2026-08-26 | 5.41 |
| 2026-08-25 | 5.41 |
| 2026-08-24 | 5.41 |
| 2026-08-21 | 5.41 |
| 2026-08-20 | 5.42 |
| 2026-08-19 | 5.45 |
| 2026-08-18 | 5.47 |
| 2026-08-17 | 5.43 |
| 2026-08-14 | 5.49 |
| 2026-08-13 | 5.50 |
| 2026-08-12 | 5.50 |
| 2026-08-11 | 5.49 |
| 2026-08-10 | 5.49 |
| 2026-08-07 | 5.48 |
| 2026-08-06 | 5.43 |
| 2026-08-05 | 5.07 |
| 2026-08-04 | 5.07 |
| 2026-08-03 | 5.06 |
| 2026-07-31 | 5.07 |
| 2026-07-30 | 5.05 |
| 2026-07-29 | 5.07 |
| 2026-07-28 | 5.06 |
| 2026-07-27 | 5.03 |
| 2026-07-24 | 5.08 |
| 2026-07-23 | 5.04 |
| 2026-07-22 | 5.04 |
| 2026-07-21 | 5.04 |
| 2026-07-20 | 5.04 |
| 2026-07-17 | 5.03 |
| 2026-07-16 | 5.03 |
| 2026-07-15 | 5.05 |
| 2026-07-14 | 4.98 |
| 2026-07-13 | 4.98 |
| 2026-07-10 | 5.01 |
| 2026-07-09 | 5.02 |
| 2026-07-08 | 5.00 |
| 2026-07-07 | 4.96 |
| 2026-07-06 | 4.98 |
| 2026-07-02 | 5.04 |
| 2026-07-01 | 5.05 |
| 2026-06-30 | 5.07 |
| 2026-06-29 | 5.12 |
| 2026-06-26 | 5.06 |
| 2026-06-25 | 5.07 |
| 2026-06-24 | 5.07 |
| 2026-06-23 | 5.07 |
| 2026-06-22 | 5.06 |
| 2026-06-18 | 5.07 |
| 2026-06-17 | 5.14 |
| 2026-06-16 | 5.12 |
| 2026-06-15 | 5.04 |
| 2026-06-12 | 5.04 |
| 2026-06-11 | 5.12 |
| 2026-06-10 | 5.17 |
| 2026-06-09 | 5.16 |
| 2026-06-08 | 5.13 |
| 2026-06-05 | 5.09 |
| 2026-06-04 | 5.10 |
| 2026-06-03 | 5.10 |
| 2026-06-02 | 5.16 |
| 2026-06-01 | 5.10 |
| 2026-05-29 | 5.12 |
| 2026-05-28 | 5.08 |
| 2026-05-27 | 5.12 |
| 2026-05-26 | 5.10 |
| 2026-05-22 | 5.10 |
| 2026-05-21 | 5.12 |
| 2026-05-20 | 5.11 |
| 2026-05-19 | 5.18 |
| 2026-05-18 | 5.18 |
| 2026-05-15 | 5.16 |
| 2026-05-14 | 5.16 |
| 2026-05-13 | 5.15 |
| 2026-05-12 | 5.12 |
| 2026-05-11 | 5.12 |
| 2026-05-08 | 5.10 |
| 2026-05-07 | 5.12 |
| 2026-05-06 | 4.74 |
| 2026-05-05 | 4.73 |
| 2026-05-04 | 4.73 |
| 2026-05-01 | 4.71 |
| 2026-04-30 | 4.71 |
| 2026-04-29 | 4.71 |
| 2026-04-28 | 4.71 |
| 2026-04-27 | 4.73 |
| 2026-04-24 | 4.76 |
| 2026-04-23 | 4.78 |
| 2026-04-22 | 4.78 |
| 2026-04-21 | 4.75 |
| 2026-04-20 | 4.75 |
| 2026-04-17 | 4.76 |
| 2026-04-16 | 4.76 |
| 2026-04-15 | 4.77 |
| 2026-04-14 | 4.77 |
| 2026-04-13 | 4.71 |
| 2026-04-10 | 4.74 |
| 2026-04-09 | 4.71 |
| 2026-04-08 | 4.71 |
| 2026-04-07 | 4.56 |
| 2026-04-06 | 4.54 |
| 2026-04-02 | 4.59 |
| 2026-04-01 | 4.78 |
| 2026-03-31 | 4.76 |
| 2026-03-30 | 4.70 |
| 2026-03-27 | 4.64 |
| 2026-03-26 | 4.60 |
| 2026-03-25 | 4.60 |
| 2026-03-24 | 4.60 |
| 2026-03-23 | 4.63 |
| 2026-03-20 | 4.58 |
| 2026-03-19 | 4.58 |
| 2026-03-18 | 4.53 |
| 2026-03-17 | 4.58 |
| 2026-03-16 | 4.61 |
| 2026-03-13 | 4.53 |
| 2026-03-12 | 4.56 |
| 2026-03-11 | 4.54 |
| 2026-03-10 | 4.23 |
| 2026-03-09 | 4.13 |
| 2026-03-06 | 4.12 |
| 2026-03-05 | 4.13 |
| 2026-03-04 | 4.13 |
| 2026-03-03 | 4.13 |
| 2026-03-02 | 4.09 |
| 2026-02-27 | 4.17 |
| 2026-02-26 | 4.17 |
| 2026-02-25 | 4.15 |
| 2026-02-24 | 4.15 |
| 2026-02-23 | 4.11 |
| 2026-02-20 | 4.16 |
| 2026-02-19 | 4.15 |
| 2026-02-18 | 4.13 |
| 2026-02-17 | 4.13 |
| 2026-02-13 | 4.12 |
| 2026-02-12 | 4.10 |
| 2026-02-11 | 4.08 |
| 2026-02-10 | 4.10 |
| 2026-02-09 | 4.08 |
| 2026-02-06 | 4.15 |
| 2026-02-05 | 4.15 |
| 2026-02-04 | 4.12 |
| 2026-02-03 | 4.15 |
| 2026-02-02 | 4.17 |
| 2026-01-30 | 4.05 |
| 2026-01-29 | 4.16 |
| 2026-01-28 | 4.18 |
| 2026-01-27 | 4.16 |
| 2026-01-26 | 4.21 |
| 2026-01-23 | 4.21 |
| 2026-01-22 | 4.11 |
| 2026-01-21 | 4.11 |
| 2026-01-20 | 4.14 |
| 2026-01-16 | 4.13 |
| 2026-01-15 | 4.16 |
| 2026-01-14 | 4.12 |
| 2026-01-13 | 4.08 |
| 2026-01-12 | 4.01 |
| 2026-01-09 | 4.08 |
| 2026-01-08 | 4.08 |
| 2026-01-07 | 4.08 |
| 2026-01-06 | 4.09 |
| 2026-01-05 | 4.17 |
| 2026-01-02 | 4.26 |
| 2025-12-31 | 4.03 |
| 2025-12-30 | 3.96 |
| 2025-12-29 | 3.92 |
| 2025-12-26 | 3.89 |
| 2025-12-24 | 3.90 |
| 2025-12-23 | 3.92 |
| 2025-12-22 | 3.91 |
| 2025-12-19 | 3.83 |
| 2025-12-18 | 3.83 |
| 2025-12-17 | 3.61 |
| 2025-12-16 | 3.97 |
| 2025-12-15 | 4.02 |
| 2025-12-12 | 4.17 |
| 2025-12-11 | 4.13 |
| 2025-12-10 | 4.14 |
| 2025-12-09 | 4.23 |
| 2025-12-08 | 4.21 |
| 2025-12-05 | 4.19 |
| 2025-12-04 | 4.16 |
| 2025-12-03 | 4.17 |
| 2025-12-02 | 4.22 |
| 2025-12-01 | 4.22 |
| 2025-11-28 | 4.30 |
| 2025-11-26 | 4.17 |
| 2025-11-25 | 4.20 |
| 2025-11-24 | 4.29 |
| 2025-11-21 | 4.29 |
| 2025-11-20 | 4.29 |
| 2025-11-19 | 4.31 |
| 2025-11-18 | 4.31 |
| 2025-11-17 | 4.31 |
| 2025-11-14 | 4.32 |
| 2025-11-13 | 4.31 |
| 2025-11-12 | 4.33 |
| 2025-11-11 | 4.33 |
| 2025-11-10 | 4.31 |
| 2025-11-07 | 4.31 |
| 2025-11-06 | 4.34 |
| 2025-11-05 | 4.34 |
| 2025-11-04 | 4.30 |
| 2025-11-03 | 4.34 |
| 2025-10-31 | 4.34 |
| 2025-10-30 | 4.34 |
| 2025-10-29 | 4.31 |
| 2025-10-28 | 4.32 |
| 2025-10-27 | 4.32 |
| 2025-10-24 | 4.32 |
| 2025-10-23 | 4.33 |
| 2025-10-22 | 4.33 |
| 2025-10-21 | 4.34 |
| 2025-10-20 | 4.32 |
| 2025-10-17 | 4.30 |
| 2025-10-16 | 4.30 |
| 2025-10-15 | 4.34 |
| 2025-10-14 | 4.34 |
| 2025-10-13 | 4.29 |
| 2025-10-10 | 4.28 |
| 2025-10-09 | 4.26 |
| 2025-10-08 | 4.28 |
| 2025-10-07 | 4.25 |
| 2025-10-06 | 4.28 |
| 2025-10-03 | 4.28 |
| 2025-10-02 | 4.34 |
| 2025-10-01 | 4.33 |
| 2025-09-30 | 4.31 |
| 2025-09-29 | 4.33 |
| 2025-09-26 | 4.33 |
| 2025-09-25 | 4.34 |
| 2025-09-24 | 4.32 |
| 2025-09-23 | 4.34 |
Showing the most recent 260 of 1,255 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.